Literature DB >> 5917335

Respiratory antibody to Francisella tularensis in man.

E L Buescher, J A Bellanti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5917335      PMCID： PMC378236          DOI： 10.1128/br.30.3.539-541.1966

Source DB:  PubMed          Journal:  Bacteriol Rev        ISSN： 0005-3678


× No keyword cloud information.
  6 in total

1.  IDENTIFICATION OF THE ANTIVIRAL SUBSTANCES IN NASAL SECRETIONS.

Authors:  M S ARTENSTEIN; J A BELLANTI; E L BUESCHER
Journal:  Proc Soc Exp Biol Med       Date:  1964-11

2.  CHARACTERIZATION OF VIRUS NEUTRALIZING ANTIBODIES IN HUMAN SERUM AND NASAL SECRETIONS.

Authors:  J A BELLANTI; M S ARTENSTEIN; E L BUESCHER
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

3.  Hemagglutination test in tularemia: results in 56 vaccinated persons with laboratory acquired infection.

Authors:  N D CHARKES
Journal:  J Immunol       Date:  1959-08       Impact factor: 5.422

4.  Studies on human infection with Pasteurella tularensis; comparison of streptomycin and chloramphenicol in the prophylaxis of clinical disease.

Authors:  F R McCRUMB; M J SNYDER; T E WOODWARD
Journal:  Trans Assoc Am Physicians       Date:  1957

5.  Aerogenic immunization of man with live Tularemia vaccine.

Authors:  R B Hornick; H T Eigelsbach
Journal:  Bacteriol Rev       Date:  1966-09

6.  Observations on the agglutination of polysaccharide-treated erythrocytes by tularemia antisera.

Authors:  M M ALEXANDER; G G WRIGHT; A C BALDWIN
Journal:  J Exp Med       Date:  1950-06-01       Impact factor: 14.307
  6 in total
  1 in total

1.  [Investigations on the serologic activity of immunoglobulins of bronchial mucus in chronic obstructive airway diseases (author's transl)].

Authors:  S Szabó; B Rasche; E Módy
Journal:  Pneumonologie       Date:  1973-10-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.